- Report
- August 2025
- 196 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- August 2025
- 198 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- August 2025
- 197 Pages
Global
From €3173EUR$3,545USD£2,772GBP
€3526EUR$3,939USD£3,080GBP
- Report
- January 2026
- 186 Pages
Global
From €4028EUR$4,500USD£3,519GBP
- Report
- April 2025
- 180 Pages
Global
From €4028EUR$4,500USD£3,519GBP
- Report
- April 2026
- 184 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 263 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 295 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 504 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 191 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 167 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 263 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- April 2026
- 462 Pages
Global
From €5237EUR$5,850USD£4,574GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP
- Report
- February 2026
- 250 Pages
Global
From €4019EUR$4,490USD£3,511GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more